EMERGENCY PHYSICIANS' PERCEPTION OF BARRIERS AND FACILITATORS FOR ADOPTING AN OPIOID PRESCRIBING GUIDELINE IN OHIO: A QUALITATIVE INTERVIEW STUDY

被引:12
|
作者
Penm, Jonathan [1 ]
MacKinnon, Neil J. [2 ]
Connelly, Chloe [2 ]
Mashni, Rebecca [3 ]
Lyons, Michael S. [4 ]
Hooker, Edmond A. [4 ]
Winstanley, Erin L. [5 ]
Carlton-Ford, Steve [6 ]
Tolle, Erica [2 ]
Boone, Jill [2 ]
Koechlin, Kathleen [7 ]
Defiore-Hyrmer, Jolene [7 ]
机构
[1] Univ Sydney, Sch Pharm, Camperdown, NSW, Australia
[2] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH USA
[3] Boston Univ, Law Sch, Boston, MA USA
[4] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA
[5] West Virginia Univ, Sch Med, Dept Behav Med & Psychiat, Morgantown, WV USA
[6] Univ Cincinnati, McMicken Coll Arts & Sci, Cincinnati, OH USA
[7] Ohio Dept Hlth, Columbus, OH 43266 USA
来源
JOURNAL OF EMERGENCY MEDICINE | 2019年 / 56卷 / 01期
关键词
opioid; prescribing; guidelines; Ohio; emergency; UNITED-STATES; PRESCRIPTIONS; PAIN;
D O I
10.1016/j.jemermed.2018.09.005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Ohio has the fifth highest rate of prescription opioid overdose deaths in the United States. One strategy implemented to address this concern is a state-wide opioid prescribing guideline in the emergency department (ED). Objective: Our aim was to explore emergency physicians' perceptions on barriers and strategies for the Ohio ED opioid prescribing guideline. Methods: Semistructured interviews with emergency physicians in Ohio were conducted from October to December 2016. Emergency physicians were recruited through the American College of Emergency Physicians Ohio State Chapter. The interview guide explored issues related to the implementation of the guidelines. Interview data were transcribed and thematically analyzed and coded using a scheme of inductively determined labels. Results: In total, we conducted 20 interviews. Of these, 11 were also the ED medical director at their institution. Main themes we identified were: 1) increased organizational responsibility, 2) improved prescription drug monitoring program (PDMP) integration, 3) concerns regarding patient satisfaction scores, and 4) increased patient involvement. In addition, some physicians wanted the guidelines to contain more clinical information and be worded more strongly against opioid prescribing. Emergency physicians felt patient satisfaction scores were perceived to negatively impact opioid prescribing guidelines, as they may encourage physicians to prescribe opioids. Furthermore, some participants reported that this is compounded if the emergency physicians' income was linked to their patient satisfaction score. Conclusions: Emergency physicians interviewed generally supported the state-wide opioid prescribing guideline but felt hospitals needed to take additional organizational responsibility for addressing inappropriate opioid prescribing. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [41] Barriers and facilitators to targeted anxiety prevention programmes in families at risk: a qualitative interview study
    Lawrence, P. J.
    Harvey, K.
    Williams, C.
    Creswell, C.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2022, 31 (04) : 565 - 575
  • [42] A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
    David Wiercigroch
    Patricia Hoyeck
    Hasan Sheikh
    Jennifer Hulme
    BMC Emergency Medicine, 21
  • [43] A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
    Wiercigroch, David
    Hoyeck, Patricia
    Sheikh, Hasan
    Hulme, Jennifer
    BMC EMERGENCY MEDICINE, 2021, 21 (01)
  • [44] Response to “understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study”
    Jason W. Busse
    David Juurlink
    D. Norman Buckley
    Gordon H. Guyatt
    BMC Family Practice, 21
  • [45] Response to "understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study"
    Busse, Jason W.
    Juurlink, David
    Buckley, D. Norman
    Guyatt, Gordon H.
    BMC FAMILY PRACTICE, 2020, 21 (01)
  • [46] Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study
    Aladul, Mohammed Ibrahim
    Fitzpatrick, Raymond William
    Chapman, Stephen Robert
    BMJ OPEN, 2018, 8 (11):
  • [47] Implementation of the clinical practice guideline for individuals with amputations in Colombia: a qualitative study on perceived barriers and facilitators
    Daniel F. Patiño-Lugo
    María del Pilar Pastor Durango
    Luz Helena Lugo-Agudelo
    Ana María Posada Borrero
    Verónica Ciro Correa
    Jesús Alberto Plata Contreras
    Claudia Yaneth Vera Giraldo
    Daniel Camilo Aguirre-Acevedo
    BMC Health Services Research, 20
  • [48] Barriers and facilitators and the need for a clinical guideline for microbiological diagnostic testing in the hospital: a qualitative and quantitative study
    Bogers, Saskia J.
    van Daalen, Frederike, V
    Kuil, Sacha D.
    de Jong, Menno D.
    Geerlings, Suzanne E.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (05) : 913 - 920
  • [49] Implementation of the clinical practice guideline for individuals with amputations in Colombia: a qualitative study on perceived barriers and facilitators
    Patino-Lugo, Daniel F.
    Pastor Durango, Maria del Pilar
    Lugo-Agudelo, Luz Helena
    Posada Borrero, Ana Maria
    Ciro Correa, Veronica
    Plata Contreras, Jesus Alberto
    Vera Giraldo, Claudia Yaneth
    Aguirre-Acevedo, Daniel Camilo
    BMC HEALTH SERVICES RESEARCH, 2020, 20 (01)
  • [50] Barriers and facilitators and the need for a clinical guideline for microbiological diagnostic testing in the hospital: a qualitative and quantitative study
    Saskia J. Bogers
    Frederike V. van Daalen
    Sacha D. Kuil
    Menno D. de Jong
    Suzanne E. Geerlings
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 913 - 920